Day: January 8, 2022

Core One Labs Now Also Working to Biosynthesize DMT and Receives License

Core One Labs Now Also Working to Biosynthesize DMT and Receives License

VANCOUVER, British Columbia, Jan. 08, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that it has progressed its work on biosynthesizing N,N-Dimethyltryptamine (“DMT”) and has been approved by Health Canada to add N,N-Dimethyltryptamine (“DMT”) to the schedule of approved controlled substances under the existing licence granted by the Controlled Drugs and Substances Act (”CDSA”) Dealer’s Licence (the “Licence”) which allows its wholly owned subsidiary Vocan Biotechnologies Inc. (“Vocan”) to research and produce biosynthetic psilocybin. Furnished with its renewed licence in the second half of 2021, and having now received approval to add DMT to its licence coverage, the Company’s wholly-owned subsidiary Vocan Biotechnologies...

Continue reading

COVAXIN™ (BBV152) Booster Dose Study Demonstrates Robust Immune Responses and Long-Term Safety

COVAXIN™ (BBV152) Booster Dose Study Demonstrates Robust Immune Responses and Long-Term Safety

Participants receiving a booster dose six months after second dose of COVAXIN™ saw significant increase (>10-fold across Alpha, Beta, Delta and Delta Plus variants) in neutralizing titers compared to baseline at six months Persistence of memory B and T cell immune responses at six months post second dose Pronounced SARS-CoV-2-specific T cell response to COVAXIN™ before and after the booster dose may confer durable and long-term protective efficacy No serious adverse events such as hospitalizations or deaths were reported Effectiveness of COVAXIN™ against the Omicron strain is currently being studied and will be reported shortly MALVERN, Pa., Jan. 08, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced...

Continue reading

Clear Blue Technologies Provides Update to Convertible Debenture Financing and Engages Firm to Drive Social Media Engagement

Clear Blue Technologies Provides Update to Convertible Debenture Financing and Engages Firm to Drive Social Media Engagement

TORONTO, Jan. 07, 2022 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (“Clear Blue”) (TSXV: CBLU), the Smart Off-Grid™ Company, today announces an adjustment to the previously announced issuance of convertible unsecured subordinated debentures in 2021. The Company completed a private placement offering of convertible unsecured subordinated debentures (the “Debentures”) for gross proceeds of C$2,799,000. With the second tranche completed, and cumulative gross proceeds of C$4,334,000 (the “Offering”), the Company still exceeded the cumulative funding target of C$4 million, previously announced on October 29, 2021. As a result of this change, corrections in the previously announced finders’ fees and broker warrants, for introducing certain subscribers to the Offering, are as follows. The Company paid finders’ fees in...

Continue reading

CVB Financial Corp. Announce Completion of the Merger with Suncrest Bank

CVB Financial Corp. Announce Completion of the Merger with Suncrest Bank

ONTARIO, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) — CVB Financial Corp. (the “Company”) announced today that the planned merger between CVBF’s wholly-owned banking subsidiary, Citizens Business Bank (“Citizens”), and Suncrest Bank (“Suncrest”) has been completed, effective at 6:00 p.m. (Pacific Standard Time) on January 7, 2022. Suncrest was merged with and into Citizens, in accordance with the terms and conditions of that certain Agreement and Plan of Reorganization and Merger (“Merger Agreement”), dated as of July 27, 2021, by and among the Company, Citizens and Suncrest, in a stock and cash transaction valued at approximately $237 million in aggregate, or $18.63 per Suncrest share based on CVB Financial Corp.’s closing stock price of $22.87 on January 7, 2022. Under the terms of the Merger Agreement, the Company issued approximately...

Continue reading

Corvus Gold Announces Intention to Delist from NASDAQ Capital Market

Corvus Gold Announces Intention to Delist from NASDAQ Capital Market

VANCOUVER, British Columbia, Jan. 07, 2022 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, NASDAQ: KOR) announces that it has notified the NASDAQ of its intention to voluntarily delist all of its securities from the Nasdaq Capital Market (“NASDAQ”), assuming satisfaction of the closing conditions of the previously announced plan of arrangement (the “Arrangement”) between Corvus, 1323606 B.C. Unlimited Liability Company, and AngloGold Ashanti Holdings plc., including the approval of the Arrangement by, and the obtainment of the final order from, the Supreme Court of British Columbia, and the successful completion of the transaction. Following the completion of the Arrangement, the Company will become a wholly-owned indirect subsidiary of AngloGold Ashanti Limited. The Company has submitted a notice...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.